|
Made
for each other
A merger or an acquisition ( M&A) may be one of the most
crucial decisions taken by a pharma company;however, its implementation
is equally imporant.Nandini Patwardhan finds out more.
Communication
vital to post-merger integration
Pradip Nayak, the Non Executive Director, GSK India, was at
the helm of affairs when Glaxo India and SmithKline Beecham
were merging. Here's how he says the merger of GSK worked
out, a move which made it the biggest pharma company in the
world.
'Buying
it at the right price is vital'
'Partnerships must prosper' is the motto behind M&A deals
undertaken by Nicholas Piramal. Swati Piramal, Director-Strategic
Alliances and Communications, of the company shares her experience
with M&As.
Training-A
Key to Distinctive Marketing
The sales force in pharma companies is facing a whole new
set of challenges including getting quality time with doctors.
With that in mind it is critical for representatives to possess
the perfect skill set through training, says Shailesh Gadre.
The
road less travelled
Shantha Biotechnics was created to provide economically viable
vaccines to Indian masses, and in the future the organisation
plans to tread a self created path by manufacturing for markets
largely unexplored, finds Deepali Gupta.
Pharma
MNCs wage patent wars
Patent law infringement owing to transnational laws and practices
is a serious concern. Nick Burrows takes us through some prominent
IP disputes by MNCs and ways to tackle such dilemmas in the
future.
Electronic
road to patent filing
Off late many Indian pharmaceutical companies are eyeing the
"big" US market for exports. While Indian generics
and drugs are receiving approvals in good numbers, the impediment
of a faster approval is the time lag.
Optimising
Customer Management
In the current knowledge economy it is critical for companies
to store and mine data for intelligent market development.
Pfizer's CRM system is a tool that has successfully accomplished
that function. Deepali Gupta takes a look.
GCP
QA - With Arun Bhatt
|
